Our prevention and management ORN guidelines are out!

ascopubs.org/doi/10.1200/JC…
ASCO Journal of Clinical Oncology International Society of Oral Oncology MASCC Baptist Health UCSF Health Miami Cancer Institute Research

🚨Pelvic lymph node XRT improves survival for young men w/ #prostatecancer 🚨

Journal of Clinical Oncology ASCO

🗓️Median f/u 10.2 years, n=350

☢️For men <65 years WPRT improved
✅OS: HR 0.33
✅PCSM: HR 0.17

👉Post-hoc analysis of an RCT from 2005!!! Before any PSMA PET…

#Paper | Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative #BreastCancer : Results From the Phase I TROPION-PanTumor01 Study

ASCO Journal of Clinical Oncology

Access the entire article here 👇
acortar.link/1OZvq4

Just Out 🚨on Journal of Clinical Oncology

Study explores the utility of plasma kidney injury molecule-1 (pKIM-1) levels as a diagnostic and prognostic marker for renal masses, demonstrating its potential to distinguish malignant from benign masses and predict worse outcomes in renal cell…

1/ Now out at Journal of Clinical Oncology! Plasma KIM-1 (pKIM-1) helps predict benign vs malignant renal masses and is prognostic for clinical outcomes.
ascopubs.org/doi/10.1200/JC…

Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials ⁦Journal of Clinical Oncology⁩ ascopubs.org/doi/10.1200/JC…

Primary Tumor Resection Before Systemic Therapy in CRC & Unresectable Metastases
Journal of Clinical Oncology
doi.org/10.1200/JCO.23…
🔎SYNCHRONOUS & CCRe-IV; 2011 - 2017, 393 pts
🚫No survival benefit for resection of the primary tumor at baseline
🧐24% in the PTR group no CTx
🤨overall…

Are you ready to make your mark in oncology research? JCO Oncology Advances is your platform! Stay connected to be part of something revolutionary.

Sign up for alerts: brnw.ch/21wJsQj #OncTwitter

Very happy to share our study published Journal of Clinical Oncology ! ascopubs.org/doi/full/10.12…

➡️Patients with mUC with NECTIN4 amplifications (occurring in app. 25%) show remarkable responses to single-agent EV, with a 96% objective response rate compared to 32% in non-amplified cases. NECTIN4…

Get ready to elevate your research! Our brand-new journal, JCO Oncology Advances, is now accepting submissions.

Learn more: brnw.ch/21wJ5uH #OncTwitter #MedTwitter

Now online in Journal of Clinical Oncology, the results of NRG Oncology The GOG Foundation Inc. #279: #Phase II Trial of #Cisplatin , #Gemcitabine , and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma

#IMRT #vulvarcancer #ClinicalTrials #gyncsm Vulvar Cancer Vulvar Cancer

📢 Excited to share our multi-disciplinary, comprehensive review on CSF-based liquid biopsy in brain tumors, which allowed us to outline a potential roadmap to standardizing research done in this realm and optimize the integration of CSF analysis into routine clinical practice.…

New from Journal of Clinical Oncology Journals: JCO #OncologyAdvances .

• Open-access & interdisciplinary
• Committed to accelerating global cancer advancements
• Welcomes contributions from oncology clinicians, researchers, & experts

Now open for submissions! www2.cloud.editorialmanager.com/oa-ascopubs/de…

Prevalence and Cancer-Specific Patterns of Functional Disability Among US #Cancer Survivors, 2017-2022.

ascopubs.org/doi/10.1200/JC…

ASCO Journal of Clinical Oncology JCO Oncology Practice
#PallOnc #GeriOnc #SuppOnc
Dana-Farber UPMC

Just out: Nat’l Estimates of Participation of #Cancer Pts in #cancerresearch has ⬆️ from <5% to 7.1%; NCI designated cancer centers ⬆️ to 21.6%. We can still do better 💪🏻! #CommissiononCancer | ascopubs.org/doi/full/10.12… Journal of Clinical Oncology @asco Vanderbilt Hem / Onc Vanderbilt-Ingram Cancer Center #PatientCare …

Listen to Knuckleheads by Tim Gilligan and find ways to partner with patients who reject our recommended treatment and how to understand what our patients are going through. ➡️ brnw.ch/21wIC2N

Cannabis and cannabinoids in adults with cancer: ASCO guideline.

To guide clinicians, adults with cancer, caregivers, researchers, and oncology institutions on their medical use.

Journal of Clinical Oncology 📖 DOI 👉🏻 10.1200/JCO.23.02596

#cancer #cannabis #asco

Researchers from Fred Hutchinson Cancer Center, ACS CAN & peer institutions released new findings in Journal of Clinical Oncology showing that when all types of cancer research studies are considered, at least 1 in 5 people with cancer participate in some form of clinical research. fightcancer.org/releases/one-f…

Oncology is a field driven by evidence, but data alone are not enough – we need stories to find our way. Erica C Kaye ➡️ brnw.ch/21wIxNM

Have you heard? #ASCOBT24 abstracts will be published in #JCO . Submit your cutting-edge research to ASCO’s innovative oncology conference in Asia for the chance to foster collaborations that will accelerate discoveries. Submit by 11:59 PM ET on April 9 ➡️ brnw.ch/21wIwBr